The interview with Dr. John Barr and Jim Patton tackles medication safety and how PillSafe Technologies secures prescriptions, prevents abuse,…
Exeltis will be granted an exclusive license to market and distribute Theranexus' novel formulation TX01 for the treatment of two…
LYON, FRANCE / ACCESSWIRE / December 17, 2024 / Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological…
Strategic investment from Google and acceptance into Mayo Clinic Platform Accelerate program show an increasing understanding of Ubie's value to patients…
Collaboration aims to empower hyper-personalized patient experiences and drive better health outcomes. MORRISTOWN, N.J., Dec. 17, 2024 /PRNewswire/ -- Mindsprint, a…
Ginkgo Bioworks to apply its mammalian cell engineering expertise to develop new cell-based systems for treating and monitoring endocrine disorders…
VANCOUVER, BC, Dec. 17, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company")…
Princeton Facility Designated as New HeadquartersRegional Multi-Site Operations to Advance Clinical-to-Commercial Capabilities$12M Capital Investment for State-of-the-Art Operations and Digital AdvancementsNEWARK,…
WELLINGTON, FL / ACCESSWIRE / December 17, 2024 / Cellev8 Nutrition Inc (OTC PINK:CELV), a pioneer in Superoxide Dismutase (SOD)…
Dr. Gibson joining Lexaria's new scientific advisor board KELOWNA, BC / ACCESSWIRE / December 17, 2024 / Lexaria Bioscience Corp.…